Rifampicin induced shock during re-exposure for treatment of latent tuberculosis

Report outlines a rare, but potential adverse event, in a young Asian female with rheumatoid arthritis who received latent tuberculosis infection treatment prior to treatment with a biological, and developed shock with resistant hypotension on re-exposure to rifampicin.

Source:

Drug and Therapeutics Bulletin